Current review panels

Review panels are composed for specific competitions and membership will depend on the expertise needed. Panel meeting dates will be posted as they become available so that applicants may ensure timely updating of post-submission publications.

A collective list of CCS chairs, panel members, scientific officers and patient/survivor/caregiver participants will be posted each year in recognition of the outstanding contributions made by the cancer research community. Individual panel members will no longer be published.

For competitions with multiple panels – applicants indicate their panel recommendation, however, final panel selection will be determined by the panel chairs and CCS based on the panel with the most appropriate expertise.

Innovation Grant and Innovation to Impact Grant panels

I1a - Biomarkers and Genomics

Including the use of high-throughput methodologies like genomics, transcriptomics, metabolomics and radiomics applied to cancer patients or model systems to develop mechanistic or translational insight or to develop biomarkers.

Panel meeting: March 24, 2020

Paul Boutros, PhD (Chair) University of California, Los Angeles
Los Angeles, CA


I1b - Gene Regulation & Cell Biology

Including mechanisms of transcriptional control, epigenetics, chromatin structure and function, translational control, RNA biology, post-translational modifications, telomere function, DNA damage and repair, organellar biology, model organisms, angiogenesis, cell migration, cell invasion, tumour environment.

Panel meeting: February 6, 2020

Peter Greer, PhD (Chair) Queen's University
Kingston, ON


I2 - Imaging and Technology Development

Including platform and tool development, systems biology, magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasound, computer tomography (CT), radiobiology, radiotherapy, photodynamic therapy (PDT), optical imaging, microfluidics, nanotechnology.

Panel meeting: February 24, 2020

Sabine Mai, PhD (Chair) University of Manitoba
Winnipeg, MB


I3 - Immunology, Signalling and Stem Cells

Including metastasis, hormone-sensitive pathways, growth-factor mediated signalling, immunotherapies, viral therapeutics, cancer stem cells, signal transduction, innate immunity, tumour antigens, immune surveillance, hematopoiesis.

Panel meeting: March 31 & April 1, 2020

Kevin Kane, PhD (Chair) University of Alberta
Edmonton, AB


I4 - Novel Therapeutics

Including small molecule and biologic drug candidates, rational drug design, hit and target validation, compound screening, medicinal chemistry, pharmacology, drug delivery systems, drug transport, drug resistance, combination therapies and pharmacogenomics.

Panel meeting: February 11 & 12, 2020

Michael Tyers, PhD (Chair) Université de Montréal
Montréal, QC


I5 - Prevention and Quality of Life 

Including epidemiology, prevention interventions, lifestyle and environmental risk factors, health economics, health services, quality of life, survivorship, palliative care, psychosocial issues, knowledge translation and exchange.

Panel meeting: February 4, 2020

Patricia Parker, PhD (Chair) Memorial Sloan Kettering Cancer Center
New York, NY


Impact Grant panel

LOI review teleconference: June 17, 2019

Panel meeting: November 1, 2019

Shoukat Dedhar, PhD (Co-Chair) BC Cancer Agency
Vancouver, BC
Lillian Sung, MD/PhD (Co-Chair) The Hospital for Sick Children
Toronto, ON

Canadian Cancer Society Research Volunteers - 2019

In 2019, more than 140 individuals volunteered their time to serve as panel chairs, reviewers, scientific officers and patient/survivor/caregiver participants on CCS Panels. These individuals contributed a significant number of hours to ensuring that CCS is able to fund the best cancer research in Canada.

Ruth Ackerman
Tim Ahles, Memorial Sloan-Kettering Cancer Center
Alison Allan, Western University
Clemens Alt, Harvard Medical School
Rebecca Auer, Ottawa Hospital Research Institute
Kristi Baker, University of Alberta
Mark Basik, Jewish General Hospital
Tarek Bismar, University of Calgary
Nicolas Bisson, Laval University
Peter Black, University of British Columbia
Victoria Blinder, Memorial Sloan-Kettering Cancer Center
Paul Boutros, UCLA
Jonathan Bramson, McMaster University
Darren Brenner, University of Calgary
Robert Britton, Simon Fraser University
Angela Brooks-Wilson, BC Cancer
David Cescon, Princess Margaret Cancer Centre
Ronald Chen, University of North Carolina
Bradley Coe, University of British Columbia
Marc Coppolino, University of Guelph
Jocelyn Côté, University of Ottawa
Andrew Craig, Queen's University
Ralph DaCosta, Princess Margaret Cancer Centre
Brita Danielson, Alberta Health Services
Shoukat Dedhar, BC Cancer
Jim Dennis, Mount Sinai Hospital
Phedias Diamandis, University Health Network
Caroline Diorio, Laval University
Kristine Donovan, Moffitt Cancer Center & Research Institute
Michael Downey, University of Ottawa
Yannick Doyon, Laval University
Craig Earle, Sunnybrook Hospital
Sean Egan, The Hospital for Sick Children
Marc Ekker, University of Ottawa
Mary-Jane Esplen, University Health Network
Richard Fahlman, University of Alberta
Miranda Fidler-Benaoudia, Alberta Health Services
Victoria Forster, Hospital for Sick Children
William Foulkes, McGill University
Michael Fraser, Ontario Institute for Cancer Research
Livia Garzia, McGill University
James Gleason, McGill University
Steven Golick
Mary Gospodarowicz, Princess Margaret Cancer Centre
Douglas Gray, Ottawa Hospital Research Institute
Peter Greer, Queen's University
Jill Hamer-Wilson
Cynthia Hawkins, The Hospital for Sick Children
Michael Hendzel, University of Alberta
Trang Hoang, Institute for Research in Immunology and Cancer (IRIC)
Annie Huang, The Hospital for Sick Children
Timothy Hughes, University of Toronto
Rayjean Hung, Mount Sinai Hospital
David Huntsman, BC Cancer
Greta Hutton
Norman Iscove, Princess Margaret Cancer Centre
Michelle Janelsins, University of Rochester
Lindsay Jibb, The Hospital for Sick Children
Lisa Julian, Ottawa Hospital Research Institute
Kevin Kane, University of Alberta
Nagarajan Kannan, Mayo Clinic
Aly Karsan, BC Cancer
Rama Khokha, Princess Margaret Cancer Centre
Lindsay Kobayashi, University of Michigan
Michael Kolios, Ryerson University
Robert Korneluk, Children's Hospital of Eastern Ontario
Monika Krzyzanowska, Princess Margaret Cancer Centre
Benjamin Kwok, Institute for Research in Immunology and Cancer (IRIC)
Rejean Lapointe, Centre de recherche du CHUM
Adrian Levy, Dalhousie University
David Litchfield, University of Western Ontario
Johné Liu, Ottawa Hospital Research Institute
Raimar Loebenberg, University of Alberta
Carmen Loiselle, McGill University
Marian Luctkar-Flude, Queen's University
Julian Lum, BC Cancer
Mathieu Lupien, Princess Margaret Cancer Centre
Sylvie Mader, University of Montreal
Sabine Mai, University of Manitoba
Alberto Martin, University of Toronto
Deborah Mayer, University of North Carolina
Heidi McBride, McGill University
Luke McCaffrey, McGill University
Cathy McCallum
Jane McGlade, The Hospital for Sick Children
Sarah McLaughlin, Mayo Clinic
Helen McNeill, Washington University School of Medicine
Mark Minden, Princess Margaret Cancer Centre
Christopher Moraes, McGill University
Michael Moran, The Hospital for Sick Children
Ryan Morin, Simon Fraser University
Gregg Morin, BC Cancer
Mark Nachtigal, University of Manitoba
Tomas Neilan, Harvard Medical School
Torsten Nielsen, University of British Columbia
Mary-Ann O'Brien, University of Toronto
Pamela Ohashi, Princess Margaret Cancer Centre
Kostas Pantopoulos, Jewish General Hospital
Patricia Parker, Memorial Sloan-Kettering Cancer Center
Jerry Pelletier, McGill University
Claude Perreault, Université de Montréal
Stephen Pistorius, University of Manitoba
Jason Pole, Pediatric Oncology Group of Ontario
Geoff Porter, Dalhousie University
Lynne-Marie Postovit, University of Alberta
Robert Reid, University of Ottawa Heart Institute
Tony Reiman, University of New Brunswick
Jüri Reimand, Ontario Institute for Cancer Research
Brent Rexer, Vanderbilt University
Cal Roskelley, University of British Columbia
James Rutka, The Hospital for Sick Children
Catherine Sabiston, University of Toronto
Brenda Sabo, Dalhousie University
Daniel Schramek, Mount Sinai Hospital
Allen Sherman, University of Arkansas for Medical Sciences
Peter Siegel, McGill University
Poul Sorensen, BC Cancer
Kevin Stein, Emory University
Peter Stirling, BC Cancer
Lillian Sung, Hospital for Sick Children
Lee-Hwa Tai, Université de Sherbrooke
Mikko Taipale, University of Toronto
Jacques Thibodeau, University of Montreal
Carrie Thompson, Mayo Clinic
Rebecca Thornhill, University of Ottawa
Rodger Tiedemann, Princess Margaret Cancer Centre
Jill Tinmouth, Sunnybrook Research Institute
Ivan Topisirovic, Jewish General Hospital
Michel Tremblay, McGill University
Michael Tyers, University of Montreal
Jim Uniacke, University of Guelph
Josie Ursini-Siegel, Lady Davis Institute
Barbara Vanderhyden, Ottawa Hospital Research Institute
Franco Vizeacoumar, University of Saskatchewan
Ellen Warner, Sunnybrook Health Sciences Centre
Alice Wei, Memorial Sloan Kettering Cancer Center
Kristen Wells, San Diego State University
John Wilkins, University of Manitoba
Brian Wilson, University of Toronto
Kerri Winters, Oregon Health & Science University
Michael Witcher, McGill University
Bradly Wouters, Princess Margaret Cancer Centre
Jim Wright, Juravinski Cancer Centre
Gelareh Zadeh, The Toronto Western Hospital

Last modified on: January 22, 2020